Experiments for taxon Cystophora moniliformis (CYSTOSEIRACEAE)

Experiments (42 results)

Filters
Worktypes (13)
28
28
24
22
20
16
14
7
5
3
3
2
1
No match
Pharmacology (10)
4
2
1
1
1
1
1
1
1
29
No match
Compounds (31)
10
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
3
No match
Organisms (5)
14
11
9
6
2
No match
42 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
1019761
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cystophora moniliformis (CYSTOSEIRACEAE)
OCT-TRANS-5-EN-2-ONE,8-(5'(S)-HYDROXY-2'-6'-6'-TRIMETHYL-CYCLOHEX-1'-ENYL)-6-METHYL:
1311282
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Cystophora moniliformis (CYSTOSEIRACEAE)
MONILIFORMINOL A
981653
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTICONVULSANT ACTIVITY
Cystophora moniliformis (CYSTOSEIRACEAE)
FARNESYL ACETONE EPOXIDE
981648
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION AND IDENTIFICATION OF
TOXICITY ASSESSMENT(QUANTITATIVE)
Cystophora moniliformis (CYSTOSEIRACEAE)
FARNESYL ACETONE EPOXIDE
989084
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Cystophora moniliformis (CYSTOSEIRACEAE)
PENTADECA-5-9-DIENE-2-13-DIONE,6-10-14-TRIMETHYL:
1193358
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cystophora moniliformis (CYSTOSEIRACEAE)
UNDECA-TRANS-5-9-DIEN-2-OL,(5'-METHOXY-5'-METHYL-TETRAHYDROFURAN-2'-YL)-6-10-DIMETHYL: (2R,2'R,5'S):
1193355
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Cystophora moniliformis (CYSTOSEIRACEAE)
GERANYL ACETONE
1019755
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Cystophora moniliformis (CYSTOSEIRACEAE)
TOCOPHEROL,ALPHA:
1311288
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Cystophora moniliformis (CYSTOSEIRACEAE)
PENTADECA-TRANS-5-TRANS-9-CIS-13-TRIENE-2-ONE,6-10-14-TRIMETHYL: 15-HYDROXY:
1019756
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cystophora moniliformis (CYSTOSEIRACEAE)
PENTADECA-TRANS-5-TRANS-9-DIEN-2-ONE,13-(R)-14-DIHYDROXY-6-10-14-TRIMETHYL:
1019762
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cystophora moniliformis (CYSTOSEIRACEAE)
OCT-TRANS-5-EN-2-ONE,6-METHYL-8-(2'-2'-6'-TRIMETHYL-3'-6'-EPOXY-CYCLOHEX-1'-YL):
1311284
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Cystophora moniliformis (CYSTOSEIRACEAE)
OCT-5-ENE-2-ONE,6-METHYL: TRANS-8-(1R-5S)-5-HYDROXY-2-6-6-TRIMETHYL-CYCLOHEX-2-ENYL:
981654
PHARMACOLOGY OF COMPOUND - IN VIVO
HYPOTHERMIC ACTIVITY
Cystophora moniliformis (CYSTOSEIRACEAE)
FARNESYL ACETONE EPOXIDE
1311283
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Cystophora moniliformis (CYSTOSEIRACEAE)
MONILIFORMINOL B
1193359
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Cystophora moniliformis (CYSTOSEIRACEAE)
HEXADECA-TRANS-2-TRANS-6-TRANS-10-TRIENAL,14-15-EPOXY-3-7-11-15-TETRAMETHYL:
1311287
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Cystophora moniliformis (CYSTOSEIRACEAE)
PENTADECA-TRANS-5(R)-TRANS-9-DIENE-2-ONE,6-10-14-TRIMETHYL: 13-14-DIHYDROXY:
1019765
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cystophora moniliformis (CYSTOSEIRACEAE)
CYSTOPHORA MONILIFORMIS BICYCLIC METABOLITE 17
1019754
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Cystophora moniliformis (CYSTOSEIRACEAE)
FARNESYL ACETONE
981649
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTICONVULSANT ACTIVITY
Cystophora moniliformis (CYSTOSEIRACEAE)
FARNESYL ACETONE EPOXIDE
1311290
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Cystophora moniliformis (CYSTOSEIRACEAE)
981652
PHARMACOLOGY OF COMPOUND - IN VIVO
BARBITURATE POTENTIATION
Cystophora moniliformis (CYSTOSEIRACEAE)
FARNESYL ACETONE EPOXIDE
1019759
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cystophora moniliformis (CYSTOSEIRACEAE)
OCT-TRANS-5-EN-2-ONE,8-(2'-2'-DIMETHYL-3'(S)-HYDROXY-6'-METHYLENE-CYCLOHEX-1'(S)-YL)-6-METHYL:
1019764
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cystophora moniliformis (CYSTOSEIRACEAE)
NON-TRANS-5-ENE-2-9-DIONE,9-(2'-ISO-PROPYL-1'-METHYL-CYCLOBUTYL)-6-METHYL:
1311286
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Cystophora moniliformis (CYSTOSEIRACEAE)
OCT-5-ENE-2-ONE,6-METHYL: TRANS-8(S)-(5-HYDROXY-2-6-6-TRIMETHYL-CYCLOHEX-1-ENYL):
1019753
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Cystophora moniliformis (CYSTOSEIRACEAE)
PENTADECA-TRANS-5-TRANS-9-DIENE-2-13-DIONE,6-10-14-TRIMETHYL:
981655
PHARMACOLOGY OF COMPOUND - IN VITRO
RESPIRATION(CELLULAR)INHIBITION
Cystophora moniliformis (CYSTOSEIRACEAE)
FARNESYL ACETONE EPOXIDE
981656
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Cystophora moniliformis (CYSTOSEIRACEAE)
FARNESYL ACETONE EPOXIDE
989083
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cystophora moniliformis (CYSTOSEIRACEAE)
PENTADECA-5-9-DIENE,6-10-14-TRIMETHYL: 2-13-EPXOIDE
981651
PHARMACOLOGY OF COMPOUND - IN VIVO
BARBITURATE POTENTIATION
Cystophora moniliformis (CYSTOSEIRACEAE)
FARNESYL ACETONE EPOXIDE
1193357
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cystophora moniliformis (CYSTOSEIRACEAE)
PENTADECA-TRANS-9-13-DIEN-2-ONE,TRANS-5-6-EPOXY-6-10-14-TRIMETHYL:
1019758
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cystophora moniliformis (CYSTOSEIRACEAE)
PENTADECA-TRANS-5-TRANS-9-DIEN-2-ONE,11-14-EPOXY-6-10-14-TRIMETHYL:
1019752
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Cystophora moniliformis (CYSTOSEIRACEAE)
PENTADECA-TRANS-5-TRANS-9-DIEN-2-ONE,13-(R)-14-EPOXY-6-10-14-TRIMETHYL:
1193356
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Cystophora moniliformis (CYSTOSEIRACEAE)
PENTADECA-TRANS-5-TRANS-9-DIEN-2-ONE,13-14-EPOXY-6-10-14-TRIMETHYL:
1311285
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Cystophora moniliformis (CYSTOSEIRACEAE)
OCT-5-ENE-2-ONE,6-METHYL: TRANS-8-(1R-3S)-3-HYDROXY-2-2-DIMETHYL-6-METHYLENE-CYCLOHEXYL:
1019763
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cystophora moniliformis (CYSTOSEIRACEAE)
CYSTOPHORA MONILIFORMIS CYCLOHEXANE METABOLITE 15
1193360
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Cystophora moniliformis (CYSTOSEIRACEAE)
HEXADECA-CIS-2-TRANS-6-TRANS-10-TRIENAL,14-15-EPOXY-3-7-11-15-TETRAMETHYL:
981647
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTICONVULSANT ACTIVITY
Cystophora moniliformis (CYSTOSEIRACEAE)
981657
PHARMACOLOGY OF COMPOUND - IN VITRO
CARDIAC DEPRESSANT ACTIVITY
Cystophora moniliformis (CYSTOSEIRACEAE)
FARNESYL ACETONE EPOXIDE
1019760
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cystophora moniliformis (CYSTOSEIRACEAE)
OCT-TRANS-5-EN-2-ONE,8-(5'(S)-HYDROXY-2'-6'-6'-TRIMETHYL-CYCLOHEX-2'-ENYL)-6-METHYL:
1311289
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Cystophora moniliformis (CYSTOSEIRACEAE)
1019757
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Cystophora moniliformis (CYSTOSEIRACEAE)
PENTADECA-TRANS-5-TRANS-9-14-TRIEN-2-ONE,13-(R)-HYDROXY-6-10-14-TRIMETHYL:
981650
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTICONVULSANT ACTIVITY
Cystophora moniliformis (CYSTOSEIRACEAE)
FARNESYL ACETONE EPOXIDE